ARCHIVES

Also FDA clarifies data requirements for phase I IND applications.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Two Court Rulings Conflict In Paclitaxel Patent Battle.

January 18, 2002

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

Upton Explains New NCI System: Rants Funded “Across The Board” Strictly By Priority Score

August 25, 1978

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

In Brief: Organ systems Coordinating Center Decision Still Delayed; Branch Merged With DCPC Centers Branch

June 29, 1984